DOI: 10.1055/s-00000071

Seminars in Neurology


Montalban X, Hemmer B, Rammohan K , et al.
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis—results of the phase III double-blind, placebo controlled ORATORIO Study.
Presented at: 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis; October 10, 2015; Barcelona, Spain

Download Bibliographical Data

Search in: